| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/31/2005 | WO2003044178A8 Hybrid oligonucleotide primers for amplification of dna and uses thereof |
| 03/31/2005 | WO2003040329A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/31/2005 | WO2003018756A3 Methods for preparing purified prostaglandin e synthase |
| 03/31/2005 | WO2003014699A3 Compositions and methods for detecting and quantifying cox-2 activity by lipoamino acid metabolism |
| 03/31/2005 | WO2002099054A3 Hccss as modifiers of the p53 pathway and methods of use |
| 03/31/2005 | US20050071894 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 03/31/2005 | US20050071892 Techniques and applications of establishment of SARS-CoV primate model |
| 03/31/2005 | US20050071087 Systems and methods for detecting biological features |
| 03/31/2005 | US20050071086 Metabolism circuit information processing method, metabolism circuit information processor, program, and recording medium |
| 03/31/2005 | US20050070777 Blood sugar level measuring method and apparatus |
| 03/31/2005 | US20050070770 Method and device for monitoring analyte concentration by optical detection |
| 03/31/2005 | US20050070708 May be used for the analysis of nucleic acid sequences by incorporating these derivatives into nucleic acid chains, and also the enzymatic labelling and immobilization or detection of sequences |
| 03/31/2005 | US20050070699 Nucleotide sequences coding low density lipoprotein receptor-related protein 5 for use as tools in diagnosis and treatment of osteoporosis; high bone mass and bone disorders |
| 03/31/2005 | US20050070691 Polypeptides of moraxella (branhamella) catarrhalis |
| 03/31/2005 | US20050070689 Nucleotide sequences coding transmembrane activator and CAML interactor (TACI) protein for use in treatment and prevention of autoimmune disorders |
| 03/31/2005 | US20050070612 Monitoring cell proliferation of prostate cancer cells; incubation with quercetin; monitoring adjustment of gene expression |
| 03/31/2005 | US20050070607 Prevent liver damage; respiratory system disorders; cardiovascular disorders; endocrine disorders; infections; monitoring concentration of glutathion in blood |
| 03/31/2005 | US20050070567 Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway |
| 03/31/2005 | US20050070506 Use as immunosuppressants; Sphingosine-1-phosphate (S1P1); bioassay for drugs; treating autoimmune and inflammatory diseases, e.g. respiratory diseases, infections, cancer, liver disorders, transplant rejection and graft vs host disease; use of amine-functional phosphonic acid compounds for example |
| 03/31/2005 | US20050070499 Administering neuropeptide y inhibitor |
| 03/31/2005 | US20050070473 administering parathyroid hormone; antiapoptotic agents; bone disorders |
| 03/31/2005 | US20050070029 Reaction method with use of biochemical analysis unit |
| 03/31/2005 | US20050070028 Method for manufacturing antibody detector and method for detecting antibody |
| 03/31/2005 | US20050070024 Using stable isotope labeled internal standard; solvent extraction |
| 03/31/2005 | US20050070023 Method of analysis of carboxylic acid by mass spectrometry |
| 03/31/2005 | US20050070022 Via oxime internal standard which is contacted with alkoxylamine; solvent extraction; quantitative analysis |
| 03/31/2005 | US20050070021 Iconic colorimetric test device with reduced susceptibility to false positive and false negative readings |
| 03/31/2005 | US20050070020 Using biopolymer sensors to identify and screen histological tissues; diagnosing cell proliferative disorders; high throughput assay |
| 03/31/2005 | US20050070019 Clinical laboratory test apparatus and clinical laboratory test system |
| 03/31/2005 | US20050070015 Methods of controlling proliferation of cancer cells and cell death |
| 03/31/2005 | US20050070006 Method for detecting mutagenic substances |
| 03/31/2005 | US20050070005 High throughput or capillary-based screening for a bioactivity or biomolecule |
| 03/31/2005 | US20050070002 Histidine phosphatase interacting protein with 120kd |
| 03/31/2005 | US20050069985 Assay methods and amelioration of muscular dystrophy symptoms |
| 03/31/2005 | US20050069984 Identification of sortase gene |
| 03/31/2005 | US20050069980 Transport protein for use as tool in altering in vivo pharmacokinetics of a pharmaceutical, toxic substance or xenobiotics by modulating an ability to transport acidic amino acids; antitumor agents |
| 03/31/2005 | US20050069973 Filter snapper |
| 03/31/2005 | US20050069972 Kit for detecting endotoxin |
| 03/31/2005 | US20050069971 Identifying modulators of transmembrane protein (PROLIXIN) for use in prevention and treatment of hyperlipidemia, athersclerosis, insulin resistance, diabetes and hypertension |
| 03/31/2005 | US20050069969 Identifying genetic and metabolic factors associated with physiologic coagulation response for use as tool in diagnosis, prevention and treament of chronic fatigue syndrome, fibromyalgia, gulf war illness and cardiovascular disease |
| 03/31/2005 | US20050069968 Sampling cerebrospinal fluid for antibodies; solid phase synthesis; immunoassay |
| 03/31/2005 | US20050069967 Immobilized immunoglobulin/latex fusion specific to prostate-specific antigens for use as too in detection and treatment of cell proliferative disorders; tissue targeted therapy; immunotherapy |
| 03/31/2005 | US20050069966 Using gastrin concentration as diagnostic tool in detetction and treatment of gastrointestinal disorders |
| 03/31/2005 | US20050069965 Method for screening agent acting on cell wall |
| 03/31/2005 | US20050069964 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
| 03/31/2005 | US20050069963 Diagnosing ovarian cell proliferative disorders via concentration of tumor marker antigen in blood; immunoassay |
| 03/31/2005 | US20050069962 Antibody complexes and methods for immunolabeling |
| 03/31/2005 | US20050069961 Isotope-coded affinity tag |
| 03/31/2005 | US20050069960 Which induce proliferation of tumor-infiltrating lymphocytes without systemic toxicity associated with the administration of wild-type cytokines; drug screening/design |
| 03/31/2005 | US20050069959 Method and apparatus for classifying B-lymphocytes |
| 03/31/2005 | US20050069958 Using solid support comprising immobilized ligands as tools in quantitative and qualitative evaluation of biological samples containing both cellular targets or analytes and soluble targets or analytes. |
| 03/31/2005 | US20050069957 Methods of identifying kinetically stable proteins |
| 03/31/2005 | US20050069955 Fragment or antibody comprising consensus sequence hexapeptide; anticarcinogenic, antitumor, antimetastasis, and antiinflammatory agents; autoimmune and cardiovascular disorders; leukemia; library of immunoglobulin binding domains having a diverse antigen-binding domain for complementary binding |
| 03/31/2005 | US20050069954 Device for determining polypetide configuration; determining protein function and structure |
| 03/31/2005 | US20050069953 Buffered assay solutions for performing binding and/or functional assays on g-protein coupled receptor arrays |
| 03/31/2005 | US20050069952 Parathyroid hormone component comprising matrix protein for use as diagnostic control in monitoring hormone levels; bioassay |
| 03/31/2005 | US20050069951 Identification of drugs using complementary combinatorial libraries |
| 03/31/2005 | US20050069950 Method for designing polypeptides for the nanofabrication of thin films, coatings, and microcapsules by electrostatic layer-by-layer self assembly |
| 03/31/2005 | US20050069949 Microfabricated Fluidic Structures |
| 03/31/2005 | US20050069948 Using suppressor of early growth response-1 (Egr-1) protein as tool in treatment of kidney disorders |
| 03/31/2005 | US20050069946 Expression analysis of FKBP54 in the diagnosis and treatment of prostate cancer |
| 03/31/2005 | US20050069944 Nucleotide sequences coding G-protein coupled receptor for use in identifying modulator of tase transduction; flavoring and food processing |
| 03/31/2005 | US20050069943 101 human secreted proteins |
| 03/31/2005 | US20050069942 Vaccine vector comprising isolated nucleic acid molecule which encodes sequence 2 linked to promoter |
| 03/31/2005 | US20050069937 Spotting method onto and data reading method from biochemical analysis unit |
| 03/31/2005 | US20050069935 Using flourescence activated cell sorting as tool in detection and classification of preferential biopolymers; diagnosing infection, nervous system, pancreatic and muscular disorders |
| 03/31/2005 | US20050069932 Apparatus comprising solid support which utilizes irradiated light to detection preferential biopolymer sequences; DNA /biochips |
| 03/31/2005 | US20050069931 Non-invasive diagnostic test utilizing histone modification markers |
| 03/31/2005 | US20050069924 Differentially methylated sequences in pancreatic cancer |
| 03/31/2005 | US20050069923 Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus |
| 03/31/2005 | US20050069922 Using presence of short expansion sequences in poly(A) binding protein II (PAB II) gene as diagnostic indicator of disease associated with polyalanine and protein accumulation in nucleus |
| 03/31/2005 | US20050069920 Using encapuslated gene sequences as tools for directed evolution of nucleic acids; microencapsulation and gene expression |
| 03/31/2005 | US20050069918 Using jun activation domain-binding protein 1 (JAB-1 protein) as diagnostic and prognostic tool for treatment and prevention of cell proliferative disorders of breast and lung |
| 03/31/2005 | US20050069916 Set of reporter signals use in detection of polymorphisms associated with metabolic and developmental disorders; multiplex detection and analysis of analytes and biomolecules |
| 03/31/2005 | US20050069913 Devices and methods for using centripetal acceleration to drive fluid movement in a microfluidics system |
| 03/31/2005 | US20050069912 Energy transfer dyes with enhanced fluorescence |
| 03/31/2005 | US20050069911 Proteome epitope tags and methods of use thereof in protein modification analysis |
| 03/31/2005 | US20050069905 Detection of molecular binding events |
| 03/31/2005 | US20050069904 Analysis of real-time PCR data |
| 03/31/2005 | US20050069900 Analyte sample detection |
| 03/31/2005 | US20050069896 Rb pathway and chromatin remodeling genes that antagonize let-60 Ras signaling |
| 03/31/2005 | US20050069895 Compositions, methods, and kits for fabricating coded molecular tags |
| 03/31/2005 | US20050069893 Diagnostic method for glaucoma |
| 03/31/2005 | US20050069892 Using time-varying potentials superimposed on a direct current potentials as tool in detection of preferential biopolymers in solution; improving the accuracy and productivity of sensors via digital signal processing techniques |
| 03/31/2005 | US20050069888 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 03/31/2005 | US20050069883 Melanin-concentrating hormone receptor antagonist binding protein |
| 03/31/2005 | US20050069880 Bioassay method, bioassay device, and bioassay substrate |
| 03/31/2005 | US20050069878 Proteins associated with cell growth, differentiation, and death |
| 03/31/2005 | US20050069877 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders |
| 03/31/2005 | US20050069876 Polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune, inflammatory, cardiovascular, neurological and developmental disorders. |
| 03/31/2005 | US20050069874 Using structural characteristic of preferential DNA fragments as tool in forensic identification; bioinformatics |
| 03/31/2005 | US20050069873 Nucleotide sequences coding insulin like growth factor binding protein-3 (IGFBP-3) receptor for use as tool in diagnosis, prevention and treatment of cell proliferative disorders |
| 03/31/2005 | US20050069869 Nucleotide sequences coding severe acute respiratory syndrome (SARS) spike glycoprotein for use as tool in development of immunoglobulins for prevention and treatment of respiratory system disorders; immunotherapy; imunodiagnostics |
| 03/31/2005 | US20050069868 Method of evaluating the immunological activity of a vaccine |
| 03/31/2005 | US20050069865 Synthetic hcv envelope proteins and their use for vaccination |
| 03/31/2005 | US20050069594 Pharmaceutical compositions and methods for the prevention of breast and ovarian cancer |
| 03/31/2005 | US20050069589 cross-linkable protein in the form of a solution or suspension; cross-linking agent solution includes an aldehyde and an amino acid containing species reactive with the aldehyde |
| 03/31/2005 | US20050069578 Reconstitution medium for protein and peptide formulations |
| 03/31/2005 | US20050069569 Osteocalcin; enzyme inhibitors; promote bone, teeth growth; administering Dna gene |
| 03/31/2005 | US20050069558 Machine readable media embedded in three-dimensional matrix; severe acute respiaroty system; crystal structure polypeptide; detection; drug design |